← Back to headlines
Legend Biotech Stock Jumps 42% on Positive Cancer Therapy Results
Legend Biotech (LEGN) shares soared by 42% following the announcement of promising results from its cancer therapy trials, exciting investors in the biotech sector.
3 Jun, 00:14 — 3 Jun, 00:14
Sources
Showing 1 of 1 sources
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Philippines Distributes Ube Planting Materials to Farmers
just now
Human Settlements Department Warns Public Against Illegal Installment Lots in Soccsksargen
just now
African Swine Fever Kills 500 Pigs in Negros Occidental Town
just now